Annual Report

Viridian Therapeutics, Inc.\DE Filed 2023-03-09 Acc 0001590750-23-000002

Documents 1

2024-02-27 10-K Annual Report
2023-03-10 S-8 Securities Offered to Employees in Benefit Plans
2023-03-10 8-K Regulation FD disclosure
2023-03-10 4 General Counsel and Secretary sold 29,971 shares at $29.07 ($871,257)
2023-03-09 10-K Annual Report
2023-03-08 8-K Results of operations
2022-03-11 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading vrdn-20221231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…